BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4029463)

  • 1. Repigmentation of vitiligo macules treated topically with Efudix cream.
    Szekeres E; Morvay M
    Dermatologica; 1985; 171(1):55-9. PubMed ID: 4029463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topically administered fluorouracil in vitiligo.
    Tsuji T; Hamada T
    Arch Dermatol; 1983 Sep; 119(9):722-7. PubMed ID: 6614958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study.
    Ortonne JP; MacDonald DM; Micoud A; Thivolet J
    Br J Dermatol; 1979 Jul; 101(1):1-12. PubMed ID: 113025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
    Rojas-Urdaneta JE; Poleo-Romero AG
    Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical tacrolimus for treatment of childhood vitiligo in Asians.
    Kanwar AJ; Dogra S; Parsad D
    Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
    Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
    J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles.
    Ortonne JP; Schmitt D; Thivolet J
    J Invest Dermatol; 1980 Jan; 74(1):40-2. PubMed ID: 7351492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical tacrolimus for repigmentation of vitiligo.
    Grimes PE; Soriano T; Dytoc MT
    J Am Acad Dermatol; 2002 Nov; 47(5):789-91. PubMed ID: 12399778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series.
    Tanghetti EA
    Cutis; 2003 Feb; 71(2):158-62. PubMed ID: 12635898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of microdermabrasion and 5-fluorouracil to induce repigmentation in vitiligo: an observational study.
    Garg T; Chander R; Jain A
    Dermatol Surg; 2011 Dec; 37(12):1763-6. PubMed ID: 21834930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies.
    Bleehen SS
    Br J Dermatol; 1976 Mar; 94 suppl 12():43-50. PubMed ID: 773413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir.
    Dogra S; Kumar B
    Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evaluation of Vitiligous lesions Repigmentation after the Administration of Atorvastatin calcium salt and Simvastatin-acid sodium salt in patients with active vitiligo (EVRAAS), a pilot study: study protocol for a randomized controlled trial.
    Niezgoda A; Winnicki A; Kosmalski T; Kowaliszyn B; Krysiński J; Czajkowski R
    Trials; 2019 Jan; 20(1):78. PubMed ID: 30683146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of segmental vitiligo to 0.05% clobetasol propionate cream.
    Khalid M; Mujtaba G
    Int J Dermatol; 1998 Sep; 37(9):705-8. PubMed ID: 9762827
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
    Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
    Hartmann A; Bröcker EB; Hamm H
    J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream.
    Souza Leite RM; Craveiro Leite AA
    Int J Dermatol; 2007 Sep; 46(9):986-9. PubMed ID: 17822508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo.
    Khalid M; Mujtaba G; Haroon TS
    Int J Dermatol; 1995 Mar; 34(3):203-5. PubMed ID: 7751099
    [No Abstract]   [Full Text] [Related]  

  • 20. Melanogenesis from topical mechlorethamine and analogues in skin of hairless mice and in vitiligo.
    Van Scott EJ; Yu RJ
    J Invest Dermatol; 1975 Nov; 65(5):476-8. PubMed ID: 1194712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.